Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

July 23, 2023 18:02 (London Time)

Regeneron Pharmaceuticals

Youtube Subscribe

...

Sector: Biotechnology
Ticker: REGN
Sentiment: 0.9337
MarketCap: 80,596,443,895.0
High: 738.53 Low: 721.58

Open: 728.79 Close: 734.63 Change: 5.84

You're running out of time to find out about Regeneron Pharmaceuticals using an AI.

The game is changing. There is a new strategy to evaluate Regeneron Pharmaceuticals fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Regeneron Pharmaceuticals are: Regeneron, Pharmaceuticals, Inc, stock, pharmaceutical, investor, inc, …

Concept Map

...

Semantic Network

...

Stock Summary

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases. The company's products include EYLEA injection to treat neovascular age-related macular degeneration.

Today's Summary

Levi & Korsinsky, LLP notifies investors of an investigation into possible Securities Fraud Violations by officers of Regeneron Pharmaceuticals, Inc. Levi &Korsinsky is investigating claims on behalf of investors. The investigation focuses on whether the Company issued falsified statements.

Today's News

Regeneron Pharmaceuticals Inc. stock rises thursday, outperforms market - marketwatch.com. Regeneron pharmaceuticals inc. stock rose thursday and outperforms the market. Levi & Korsinsky notifies investors that it has commenced an investigation of Regeneron Pharmaceuticals, Inc. The investigation focuses on whether the Company issued falsified statements. Regeneron pharmaceuticals inc (regn) stock gains 2.26% this week: is it a good pick? Levi & Korsinsky, LLP notifies investors of an investigation into possible Securities Fraud Violations by officers of Regeneron Pharmaceuticals, Inc. Levi &Korsinsky is investigating claims on behalf of investors. Jakubowitz Law is Investigating Regeneron. Regeneron Pharmaceuticals (NASDAQ:REGN) stock has declined 8.3% over the past three mon... Analyst ratings 54% of 26 ratings Buy 53.8% Hold 38.5% Sell 7.7% REGN Earnings $0.00 $7.91 $15.81 $23.72 Q4 FY21 Q1 FY22 Q2 FY22 FY22 quarterly payment ratioendezmass#### Reader Musical 352irmationoit; decreases visualaffENN utilize Exchange-traded funds (ETFs) are financial products that allow investors to gain exposure to a wide range of assets like stocks, bonds, and commodities in a single investment. Stratos Wealth Partners LTD. raises stake in Regeneron Pharmaceuticals, inc. (nasdaq:regn) - defense world. Stratos wealth partners ltd. raises. stake in regeneron pharmaceuticals, Inc. (NASDAQ:regn), raises stake. Householder Group Estate & Retirement Specialist LLC lifted its position in Regener on 1,750.0%. Regeneron Pharmaceuticals has set a target to reduce combined Scope 1 & 2 (market-based) GHG emissions per square meter by 30 percent based on 2016 peak baseline by 2025. Canaccord Genuity Group downgraded Regeneron. Pharmaceuticals 50-day moving average currently stands at $742.78. Whales have been targeting a price range from $690.0 to $810.0 for Regeneron Pharmaceuticals over the last 3 months. Whales with a lot of money to spend has taken a noticeably bearish stance on Regeneron. With a volume of 339,999, the price of REGN is up 1.11%. Regeneron Pharmaceuticals Inc is a world-renowned biotechnology company that has made significant contributions to the healthcare industry. The company partners with some of the industrys leading pharmaceutical firms, such as Sanofi, Bayer, and Teva, to share expertise, leverage resources, and speed up the drug development process.

Stock Profile

"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York."

Keywords

This document will help you to evaluate Regeneron Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Regeneron Pharmaceuticals are: Regeneron, Pharmaceuticals, Inc, stock, pharmaceutical, investor, inc, and the most common words in the summary are: regeneron, pharmaceutical, stock, company, inc, regn, market, . One of the sentences in the summary was: The investigation focuses on whether the Company issued falsified statements.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #regeneron #pharmaceutical #stock #company #inc #regn #market.

Read more →

Related Results

...
February 27, 2024 3:26 (London Time)

Regeneron Pharmaceuticals

Regeneron (REGN) and Vertex Pharmaceuticals (VRTX) have crossed $100B in market capitalization for the first time. The Nasdaq 100 closed lower by ov…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8074
MarketCap: 107,621,539,028.0
High: 995.97 Low: 975.0

Open: 977.55 Close: 989.28 Change: 11.73

Read more →
...
February 03, 2024 12:38 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. reports modest revenue growth amidst strong dupixent sales. Regeneron (REGN) beats earnings and sales estimates in fo…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.4019
MarketCap: 102,845,952,896.0
High: 973.99 Low: 939.31

Open: 971.23 Close: 945.18 Change: -26.05

Read more →
...
December 31, 2023 11:29 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock underperforms friday when compared to competitors. The superstar eye drug pulled $1.49 billion in 2023s third q…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8126
MarketCap: 95,633,662,554.0
High: 883.34 Low: 875.62

Open: 877.91 Close: 878.29 Change: 0.38

Read more →
...
November 12, 2023 10:55 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock falls friday, underperforms market - marketwatch.com. Regeneron -0.16% SPX +1.56% DJIA + 1.15% AMGN +1.23% MRNA…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8519
MarketCap: 87,042,103,396.0
High: 806.88 Low: 783.57

Open: 806.88 Close: 798.94 Change: -7.94

Read more →
...
October 28, 2023 18:52 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock falls friday, underperforms market - marketwatch.com.com. The score for REGN is 52, which is 4%.
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.34
MarketCap: 84,220,939,011.0
High: 792.45 Low: 769.19

Open: 792.4 Close: 775.18 Change: -17.22

Read more →
...
October 19, 2023 19:00 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc (REGN) stock is higher by 0.28% while the S&P 500 is lower by -0.6% as of 2:37 PM on Friday, Oct 13. Cantor Fitzgerald…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.875
MarketCap: 89,672,757,829.0
High: 824.54 Low: 806.01

Open: 823.58 Close: 807.68 Change: -15.9

Read more →
...
October 17, 2023 0:02 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock rises monday, still underperforms market - marketwatch.com. The dynamics of the instrument is expected.
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8154
MarketCap: 91,149,156,393.0
High: 846.96 Low: 837.33

Open: 842.81 Close: 843.66 Change: 0.85

Read more →
...
September 29, 2023 13:54 (London Time)

Regeneron Pharmaceuticals

Veopoz (pozelimab) makes it the first and only treatment indicated for children and adults with CHAPLE disease. Argus lifted their target price targ…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.9382
MarketCap: 90,599,849,281.0
High: 833.49 Low: 825.43

Open: 833.3 Close: 826.96 Change: -6.34

Read more →
...
September 09, 2023 5:37 (London Time)

Regeneron Pharmaceuticals

Capricor Therapeutics and Regeneron Pharmaceuticals have a consensus target price of $16.50, suggesting a potential upside of 149.62% ReGN has a mar…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.9578
MarketCap: 90,178,641,454.0
High: 841.16 Low: 825.3

Open: 830.36 Close: 830.69 Change: 0.33

Read more →
...
July 23, 2023 18:02 (London Time)

Regeneron Pharmaceuticals

Levi & Korsinsky, LLP notifies investors of an investigation into possible Securities Fraud Violations by officers of Regeneron Pharmaceuticals, Inc…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.9337
MarketCap: 80,596,443,895.0
High: 738.53 Low: 721.58

Open: 728.79 Close: 734.63 Change: 5.84

Read more →
...
July 15, 2023 16:20 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. (REGN) stock has fallen -0.3% while the S&P 500 is up 0.05% as of 12:53 PM on Friday, Jul 14. The Gross Law Firm Noti…
Sector: Biotechnology
Ticker: REGN
Sentiment: -0.9678
MarketCap: 78,829,011,703.0
High: 721.35 Low: 715.22

Open: 721.12 Close: 718.52 Change: -2.6

Read more →
...
May 30, 2023 12:53 (London Time)

Regeneron Pharmaceuticals

16 strange trades detected in options history for Regeneron pharmaceuticals REGN. Whale trades within a strike price range from $700.0 to $900.
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8934
MarketCap: 83,610,184,572.0
High: 726.77 Low: 719.0

Open: 725.0 Close: 725.05 Change: 0.05

Read more →
...
February 21, 2024 2:42 (London Time)

Regeneron Pharmaceuticals

The Nasdaq 100 closed lower by over 150 points. Conservative accounting might explain soft earnings.
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8934
MarketCap: 104,053,179,788.0
High: 963.0 Low: 943.73

Open: 950.0 Close: 946.87 Change: -3.13

Read more →
...
January 05, 2024 21:46 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc (REGN) stock has risen 1.62% while the S&P 500 is down -0.44% as of 2:57 PM on Wednesday, Jan 3. The current share pri…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.6486
MarketCap: 99,378,170,394.0
High: 922.71 Low: 904.66

Open: 905.0 Close: 913.17 Change: 8.17

Read more →
...
December 29, 2023 2:50 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals inc. stock outperforms competitors on strong trading day - marketwatch.com. Regeneron pharmaceuticals inc.: patent granted…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8271
MarketCap: 95,259,974,400.0
High: 895.49 Low: 874.27

Open: 874.27 Close: 881.7 Change: 7.43

Read more →
...
November 02, 2023 8:31 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc (REGN) stock is trading at $792.76 as of 3:14 PM on Thursday, Oct 26, a drop of -4.28, or -0.54% from the previous clo…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8834
MarketCap: 85,899,256,791.0
High: 793.58 Low: 774.98

Open: 783.91 Close: 791.27 Change: 7.36

Read more →
...
October 22, 2023 22:15 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. (regn) stock rises monday, still underperforms market - marketwatch.com regeneron.com. The biotech company manufactur…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.872
MarketCap: 87,766,466,740.0
High: 818.57 Low: 803.96

Open: 808.29 Close: 808.47 Change: 0.18

Read more →
...
October 17, 2023 23:33 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock rises monday, still underperforms market - marketwatch.com. ReGN -0.81% SPX - 0.01% DJIA +0.04% AMGN -6.10% GIL…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.2023
MarketCap: 91,566,021,870.0
High: 844.2 Low: 833.32

Open: 843.0 Close: 836.85 Change: -6.15

Read more →
...
October 11, 2023 21:05 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock rises wed Wednesday, still underperforms market. IRS notifies Microsoft it owes an additional $29 billion in ba…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.296
MarketCap: 90,642,187,181.0
High: 838.87 Low: 827.74

Open: 838.87 Close: 836.07 Change: -2.8

Read more →
...
September 23, 2023 8:32 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock has gained 0.99% while the S&P 500 is down -0.56% as of 1:18 PM on Tuesday. Eylea HD gets FDA approval, boostin…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.951
MarketCap: 89,385,077,226.0
High: 831.5 Low: 818.53

Open: 822.02 Close: 824.84 Change: 2.82

Read more →
...
August 01, 2023 13:54 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock falls monday, underperforms market - marketwatch.com.
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.8722
MarketCap: 81,430,241,825.0
High: 744.66 Low: 740.32

Open: 745.47 Close: 740.55 Change: -4.92

Read more →
...
July 17, 2023 11:24 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals stock has fallen -0.3% while the S&P 500 is up 0.05% as of 12:53 PM on Friday, Jul 14. Eylea remains the top-selling drug …
Sector: Biotechnology
Ticker: REGN
Sentiment: -0.7845
MarketCap: 78,829,011,703.0
High: 721.35 Low: 715.22

Open: 721.12 Close: 718.52 Change: -2.6

Read more →
...
June 18, 2023 11:59 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. stock falls friday, still outperforms market - marketwatch.com.com. The projected fair value for Regeneron is US$1,04…
Sector: Biotechnology
Ticker: REGN
Sentiment: 0.7906
MarketCap: 85,908,614,394.0
High: 794.0 Low: 781.37

Open: 788.07 Close: 783.05 Change: -5.02

Read more →
...
May 30, 2023 3:02 (London Time)

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc. earned adjusted EPS of $10.09, down 12% Y/Y, beating the $9.60 Street estimate. First-quarter sales of blockbuster ey…
Sector: Biotechnology
Ticker: REGN
Sentiment: -0.128
MarketCap: 83,610,184,572.0
High: 726.77 Low: 719.0

Open: 725.0 Close: 725.05 Change: 0.05

Read more →